Merging industriesIn mid-November, the European Commission tabled the long-awaited review of its Bioeconomy Strategy and Action Plan. European Biotechnology spoke with Waldemar Kütt, Head of Unit Bioeconomy Strategy, … more ➔
pharma labelling, pharmaceutical packaging, tamper-resistant Connectivity is the futurePharmaPack 2018:?The promises of digitalised medicine don’t stop at injection pens or autoinjectors. One of the early adopters in the field is Swiss Haselmeier AG (Pharmapack: hall 7.1, booth L19). European … more ➔
Biotech enabling Europe to reach UN SDGsThe UN Sustainable Development Goals (SDGs) provide a powerful blueprint for coordinating global efforts to end poverty through economic growth, reducing inequality, and providing better education, health, … more ➔
A suited approach to rare disease trialsOPIS Accelerated approval for orphan drugs and the possibility to have market authorisationafter a successful Phase II trial have made research in rare diseases more attractive to sponsors.However, … more ➔
4SC AG, EU patent, José Pfizer, unified patent vs bundle patent, UPC system “We have mixed feelings…”...Unitary Patent:?Ingve Stjerna, plaintiff before the Federal Constitutional Court, argues that the UPC system does not deliver on its promise to make European patents cheaper and more affordable to Small … more ➔
Align Biopharma, HCP Streamlining Digital Engagement with HCPsToday, there are greater expectations among healthcare providers for engagement with life sciences companies to be digital. For life sciences companies, there is significant potential to leverage digital … more ➔
Talents: HR FlashThe European Biotech market is extremely dynamic, acknowledged as being number two in the world of market rankings. This is a cause for celebration! more ➔
Polpharma: Making biologics economicAfter having set up a R&D hub for the biomanufacturing of clinical trial supplies in Gdansk, Polpharma is expanding its European footprint with a €100m investment in Warsaw. Several take-overs … more ➔
IP: Brexit and patentsOn 23 June 2016, the UK voted to leave the EU and, thereby, decided for Brexit. As of today, it is still uncertain what the exact implications of this decision will be, including important questions … more ➔
